Quantcast

Latest bloating Stories

2011-11-21 12:26:30

A patient's viewpoint of the severity of irritable bowel syndrome (IBS) symptoms can be influenced not only by physical symptoms of IBS but broader psychological problems, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Clinicians who face pressure to treat patients in a cost-effective manner within tight time constraints and at a satisfactory level are likely to find that patient-reported outcome...

2011-11-02 09:10:45

Among the most commonly used treatments for IBS, a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers Among the most commonly used treatments for irritable bowel syndrome — which affects as many as 20 percent of the United States population — a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers, based on an analysis of 26 large-scale clinical trials. The study, for presentation at the American...

2011-06-16 07:00:00

SAN DIEGO, June 16, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued Patent No.7,960,429 "KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME." This patent covers the use of asimadoline to treat diarrhea predominant irritable bowel syndrome (D-IBS) and has an expiration date in June, 2028. The recently issued patent is owned by Tioga Pharmaceuticals. A continuation...

2011-06-01 07:00:00

SAN DIEGO, June 1, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that its investigational compound asimadoline has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with diarrhea-predominant irritable bowel syndrome (D-IBS). Tioga is conducting a multi-center Phase 3 clinical trial evaluating asimadoline in D-IBS, conducted under a Special Protocol Assessment agreement with the FDA for U.S. registration. The...

2011-05-25 07:38:00

CROMWELL, Conn., May 25, 2011 /PRNewswire/ -- Each month, millions of women suffer from symptoms associated with premenstrual syndrome (PMS). With the introduction of the all-new AZO PMS(TM) -- the only brand available to address both physiological and emotional symptoms -- women can now get relief from PMS with a fast acting natural product. (Photo: http://photos.prnewswire.com/prnh/20110525/NE08165 ) PMS refers to a wide range of physical and emotional symptoms that typically occur...

2011-05-11 13:47:24

Linking it to bacterial overgrowth, food poisoning Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people. One study provides further evidence that IBS is linked to an overgrowth of bacteria in the gut. In a separate study, a mathematical model reveals the disease's link to food poisoning and shows that military personnel are at a much higher...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related